Answers are grounded in this paper and cite their sources.
Review reveals mechanisms linking iron overload to tissue injury in hereditary hemochromatosis, suggesting new treatment options.
Hereditary hemochromatosis (HH) is a common inherited disorder of iron metabolism characterized by excessive systemic iron accumulation resulting from dysregulation of the hepcidin–ferroportin axis. Persistent iron overload promotes oxidative stress, mitochondrial injury, chronic inflammation, and progressive damage to the liver, pancreas, heart, endocrine glands, and other organs. In recent years, ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation and impaired antioxidant defenses, has emerged as a key mechanism linking iron accumulation to tissue injury. Growing evidence suggests that ferroptosis contributes substantially to the pathogenesis and clinical manifestations of hereditary hemochromatosis. This review summarizes current knowledge regarding the molecular mechanisms of iron overload and ferroptosis in hereditary hemochromatosis, emphasizing the roles of reactive oxygen species, mitochondrial dysfunction, lipid peroxidation, glutathione metabolism, and glutathione peroxidase 4 (GPX4). The review also discusses emerging therapeutic strategies targeting iron metabolism and ferroptotic pathways, including iron chelation, hepcidin replacement therapies, ferroptosis inhibitors, and antioxidant approaches. A better understanding of the relationship between iron overload and ferroptosis may provide new opportunities for precision medicine and the development of targeted interventions for hereditary hemochromatosis.[1–5]
No takes yet. Share an insight, caveat, or question.
Tahira Asgarova*1, Huseyn Abiyev2, Nigar Malikova1, Elshad Novruzov1 (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: